ArthNow Logo
ArthNow
•2 min read•
✦Reported by MoneyControl

Govts investing heavily in bioeconomy; India best example of demand, supply growing together

Govts investing heavily in bioeconomy; India best example of demand, supply growing together
Source: MoneyControl

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓The World Economic Forum said on Tuesday that governments are investing heavily in bioeconomy development.
  • ✓India is the best example of demand and supply growing together.
  • ✓The report noted that India has a rapidly expanding bioeconomy supported by targeted national initiatives, including the Biotechnology for Economy, Environment and Employment Policy.

Story at a Glance

Category
Indian Markets
Reported By
MoneyControl
Reading Speed
2 Minute(s)
Market Focus
India Economy

Governments across the world are investing heavily in bioeconomy development and India provides the clearest example of demand and supply expanding together in this area, the World Economic Forum said on Tuesday. In its Bioeconomy Policy Index report, prepared in collaboration with Capgemini Invent, the WEF said the range of policy instruments for bioeconomy development in India reflects a strong emphasis on enabling conditions, research and development, and institutional capacity. The report analysed 935 bioeconomy policy instruments across Japan, the United Kingdom, Germany, the United States, India, China, and Brazil.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

MoneyControl

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.